BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26044663)

  • 1. Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Yao YL; Ma J
    J Mol Neurosci; 2015 Sep; 57(1):1-10. PubMed ID: 26044663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB
    J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J
    J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
    Xie H; Xue YX; Liu LB; Liu YH; Wang P
    J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
    Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
    Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
    Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
    PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity.
    Zieba BJ; Artamonov MV; Jin L; Momotani K; Ho R; Franke AS; Neppl RL; Stevenson AS; Khromov AS; Chrzanowska-Wodnicka M; Somlyo AV
    J Biol Chem; 2011 May; 286(19):16681-92. PubMed ID: 21454546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.
    Fukuhara S; Sakurai A; Sano H; Yamagishi A; Somekawa S; Takakura N; Saito Y; Kangawa K; Mochizuki N
    Mol Cell Biol; 2005 Jan; 25(1):136-46. PubMed ID: 15601837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery.
    Adamson RH; Ly JC; Sarai RK; Lenz JF; Altangerel A; Drenckhahn D; Curry FE
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1188-96. PubMed ID: 18178724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway.
    Bubik MF; Willer EA; Bihari P; Jürgenliemk G; Ammer H; Krombach F; Zahler S; Vollmar AM; Fürst R
    J Mol Cell Cardiol; 2012 Jan; 52(1):196-205. PubMed ID: 22085704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Xie H; Liu LB
    J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1.
    Yang Y; Yang F; Wu X; Lv X; Li J
    Can J Physiol Pharmacol; 2016 May; 94(5):498-507. PubMed ID: 26854595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM.
    Chepurny OG; Leech CA; Kelley GG; Dzhura I; Dzhura E; Li X; Rindler MJ; Schwede F; Genieser HG; Holz GG
    J Biol Chem; 2009 Apr; 284(16):10728-36. PubMed ID: 19244230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
    Rangarajan S; Enserink JM; Kuiperij HB; de Rooij J; Price LS; Schwede F; Bos JL
    J Cell Biol; 2003 Feb; 160(4):487-93. PubMed ID: 12578910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.
    Rajagopal S; Kumar DP; Mahavadi S; Bhattacharya S; Zhou R; Corvera CU; Bunnett NW; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(5):G527-35. PubMed ID: 23275618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.